ACE and chronic kidney disease: Inhibitors of the renin‐angiotensin system (RAS), particularly angiotensin (Ang) II receptor blockers (ARBs) and angiotensin‐converting enzyme (ACE) inhibitors, are widely adopted antiproteinuric and antihypertensive agents that prevent the progression of chronic kidney disease (Hsu et al., 2014).